SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-044633
Filing Date
2021-08-16
Accepted
2021-08-16 16:11:43
Documents
14
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANNX-8K-Q221 annx-8k_20210812.htm   iXBRL 8-K 43558
2 EX-99.1 annx-ex991_6.htm EX-99.1 294428
3 GRAPHIC gz3y3ppzlbxb000001.jpg GRAPHIC 86282
  Complete submission text file 0001564590-21-044633.txt   606776

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA annx-20210812.xsd EX-101.SCH 5677
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20210812_lab.xml EX-101.LAB 20071
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20210812_pre.xml EX-101.PRE 11930
7 EXTRACTED XBRL INSTANCE DOCUMENT annx-8k_20210812_htm.xml XML 3677
Mailing Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39402 | Film No.: 211178256
SIC: 2834 Pharmaceutical Preparations